<DOC>
	<DOCNO>NCT00272753</DOCNO>
	<brief_summary>The aim study whether budesonide component within budesonide/ formoterol combination inhaler additive value model `` slow onset acute asthma '' , namely three AMP provocation test perform one day</brief_summary>
	<brief_title>Effect Budesonide / Formoterol Combination Repeated AMP Provocations</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>asthma diagnosis accord ATS criterion , lung function ( FEV1 ) 60 % predict , AMPPC20 160 mg/ml document fall FEV1 30 % provocation test smoke &gt; 10 Packyears , hypersensitivity one study drug , significant comorbidity , pregnancy lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>